Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Lisa Araki is active.

Publication


Featured researches published by Lisa Araki.


Tetrahedron Letters | 1999

Synthesis of imifuramine and its stereoisomers exhibiting histamine H3-agonistic activity

Shinya Harusawa; Tomonari Imazu; Seiichiroh Takashima; Lisa Araki; Hirofumi Ohishi; Takushi Kurihara; Yumiko Yamamoto; Atsushi Yamatodani

Abstract The four possible stereoisomers of a novel imidazole C-nucleoside derivative were synthesized by the efficient use of a PhSe group. Among them, (+)-4(5)-[(2R,5R)-5-(aminomethyl)tetrahydrofuran-2-yl]imidazole (imifuramine) was indicated as a novel type of histamine H 3 -agonist by a brain microdialysis method.


Bioorganic & Medicinal Chemistry Letters | 2013

Synthesis and evaluation of N-alkyl-S-[3-(piperidin-1-yl)propyl]isothioureas: High affinity and human/rat species-selective histamine H3 receptor antagonists

Shinya Harusawa; Koichi Sawada; Takuji Magata; Hiroki Yoneyama; Lisa Araki; Yoshihide Usami; Kouta Hatano; Kouichi Yamamoto; Daisuke Yamamoto; Atsushi Yamatodani

S-Alkyl-N-alkylisothiourea compounds containing various cyclic amines were synthesized in the search for novel nonimidazole histamine H3 receptor (H3R) antagonists. Among them, four N-alkyl S-[3-(piperidin-1-yl)propyl]isothioureas 18, 19, 22, and 23 were found to exhibit potent and selective H3R antagonistic activities against in vitro human H3R, but were inactive against in vitro human H4R. Furthermore, three alkyl homologs 18-20 showed inactivity for histamine release in in vivo rat brain microdialysis, suggesting differences in antagonist affinities between species. In addition, in silico docking studies of N-[4-(4-chlorophenyl)butyl]-S-[3-piperidin-1-yl)propyl]isothiourea 19 and a shorter homolog 17 with human/rat H3Rs revealed that structural differences between the antagonist-docking cavities of rat and human H3Rs were likely caused by the Ala122/Val122 mutation.


Journal of Organic Chemistry | 2008

Efficient approaches to S-alkyl-N-alkylisothioureas: syntheses of histamine H3 antagonist clobenpropit and its analogues.

Hiroki Yoneyama; Ayako Shimoda; Lisa Araki; Kouta Hatano; Yasuhiko Sakamoto; Takushi Kurihara; Atsushi Yamatodani; Shinya Harusawa

S-Alkyl-N-alkylisothioureas were efficiently synthesized via synthetic approach (A) using 3-phenylpropionyl isothiocyanate (PPI). The utility of the approach was proved by the syntheses of clobenpropit, a potent histamine H(3) antagonist, and its analogues. Alternatively, clobenpropit could be prepared via intramolecular amide cleavage (B) with use of 2-nitrophenylacetyl isothiocyanate (NPAI).


Heterocycles | 2010

Synthesis of two estradiol-imidazole C-ribonucleoside hybrid compounds exhibiting inhibitory effects against type 1 17β-hydroxysteroid dehydrogenase

Shinya Harusawa; Chihiro Kojima; Kensuke Fujii; Yuusaku Yamashita; Tomoya Tanaka; Lisa Araki; Toshinobu Yoshimura; Minoru Sakaguchi; Yoshihide Usami; Masanori Takaoka

Novel estradiol-imidazole C-nucleoside hybrid compounds 4a and 4b, which have C4-linked C o - and C 2 -imidazole ribonucleosides as adenosine mimics and amide bond linkers, were designed and synthesized based on EM-1745, an inhibitor of type 1 17β-hydroxysteroid dehydrogenase (17β-HSD1). Compounds 4a and 4b were also tested as enzyme inhibitors.


Heterocycles | 2001

Synthesis of cis- or trans-2,4-Disubstituted Tetrahydrofurans Bearing Amino and Imidazole Groups by Efficient Use of the Modified or Standard Mitsunobu Cyclization: Synthetic Studies toward Novel Histamine H3-Ligands

Takushi Kurihara; Lisa Araki; Shinya Harusawa; Ikuno Ijichi; Hirofumi Ohishi

R,4S) or (2S,4S)-4-Aminotetrahydrofuran-2-yl)imidazole ((-)-1a or (-)-1b) and its enantiomers ((+)-2a and (+)-2b) were synthesized by efficient use of the modified or standard Mitsunobu cyclization.


Journal of Medicinal Chemistry | 2003

A selective human H(4)-receptor agonist: (-)-2-cyano-1-methyl-3-[(2R,5R)-5- [1H-imidazol-4(5)-yl]tetrahydrofuran-2-y] methylguanidine

Takeshi Hashimoto; Shinya Harusawa; Lisa Araki; Obbe P. Zuiderveld; Martine J. Smit; Tomonari Imazu; Seiichiroh Takashima; Yumiko Yamamoto; Yasuhiko Sakamoto; Takushi Kurihara; Rob Leurs; Remko A. Bakker; Atsushi Yamatodani


RNA | 2006

Nucleobase catalysis in the hairpin ribozyme

Timothy J. Wilson; Jonathan Ouellet; Zheng-yun Zhao; Shinya Harusawa; Lisa Araki; Takushi Kurihara; David M. J. Lilley


Journal of the American Chemical Society | 2005

Nucleobase Participation in Ribozyme Catalysis

Zheng-yun Zhao; Aileen Mcleod; Shinya Harusawa; Lisa Araki; Maho Yamaguchi; Takushi Kurihara; David M. J. Lilley


Tetrahedron | 2004

Design and synthesis of an aminobenzo-15-crown-5-labeled estradiol tethered with disulfide linkage

Shinya Harusawa; Kazufumi Yoshida; Chihiro Kojima; Lisa Araki; Takushi Kurihara


Journal of Organic Chemistry | 2009

Synthesis of Novel C4-Linked C2-Imidazole Ribonucleoside Phosphoramidite and Its Application to Probing the Catalytic Mechanism of a Ribozyme

Lisa Araki; Keiji Morita; Maho Yamaguchi; Zheng-yun Zhao; Timothy J. Wilson; David M. J. Lilley; Shinya Harusawa

Collaboration


Dive into the Lisa Araki's collaboration.

Top Co-Authors

Avatar

Shinya Harusawa

Osaka University of Pharmaceutical Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yasuhiko Sakamoto

Osaka University of Pharmaceutical Sciences

View shared research outputs
Top Co-Authors

Avatar

Maho Yamaguchi

Osaka University of Pharmaceutical Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hirofumi Ohishi

Osaka University of Pharmaceutical Sciences

View shared research outputs
Top Co-Authors

Avatar

Tomonari Imazu

Osaka University of Pharmaceutical Sciences

View shared research outputs
Researchain Logo
Decentralizing Knowledge